IDT Biologika is part of the upcoming Outsourced Pharma’s Cell & Gene Therapy Capacity Update. We will present our wide range of our services from process design to clinical and commercial manufacturing. This session will spotlight how to overcome challenges in AAV vector manufacturing as platform based approach for optimizing timeline, costs and efforts into clinics. After the presentation, you will also have the opportunity to talk to our expert.

Register now for the webinar on event.on24.com

Take a look at all of our Upcoming Events.